SEC Form 4 · accession 0001209191-16-089888
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Liptak
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 4, 2016 | M | 300 | $15.34 | A | 26,459 | D | |
| Class A Common Stock | Jan 4, 2016 | S | 300 | $27.50 | D | 26,159 | D | |
| Class A Common Stock | Jan 6, 2016 | M | 15,000 | $15.34 | A | 41,159 | D | |
| Class A Common Stock | Jan 6, 2016 | S | 15,000 | $27.50 | D | 26,159 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $15.34 | Jan 4, 2016 | M | 300 | D | — | Aug 29, 2022 | Class A Common Stock | 300 | 15,000 | D |
| Stock Option (Right to Buy Class A Common Stock)F2 | $15.34 | Jan 6, 2016 | M | 15,000 | D | — | Aug 29, 2022 | Class A Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on December 2, 2015, which is intended to comply with Rule 10b5-1.
- F2These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2012, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters.